scholarly article | Q13442814 |
P50 | author | Grzegorz Bilo | Q43169996 |
Pietro Amedeo Modesti | Q37125452 | ||
Gianfranco Parati | Q37830585 | ||
Camilla Torlasco | Q57078229 | ||
Buddha Basnyat | Q59774630 | ||
Peter Bärtsch | Q59785449 | ||
Marco Maggiorini | Q59785623 | ||
Andrew M Luks | Q89791900 | ||
Hermann Brugger | Q90096550 | ||
Bryan Williams | Q90687501 | ||
Erik R Swenson | Q96193780 | ||
P2093 | author name string | Antonio Coca | |
Piergiuseppe Agostoni | |||
Guido Giardini | |||
Luigi Festi | |||
Alessandra Lironcurti | |||
P2860 | cites work | Pre-existing cardiovascular conditions and high altitude travel. Consensus statement of the Medical Commission of the Union Internationale des Associations d'Alpinisme (UIAA MedCom) Travel Medicine and Infectious Disease | Q38199900 |
Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: the High Altitude Cardiovascular Research-Andes study | Q38412801 | ||
High-altitude pulmonary hypertension is associated with a free radical-mediated reduction in pulmonary nitric oxide bioavailability | Q42874853 | ||
Effect of Acetazolamide on Hypoxemia during Sleep at High Altitude | Q44383344 | ||
Systemic oxygen transport in patients with congenital heart disease | Q44426721 | ||
Influence of altitude exposure on coronary flow reserve | Q44562020 | ||
Ischemic changes in exercise ECG in a hypertensive subject acutely exposed to high altitude. Possible role of a high-altitude induced imbalance in myocardial oxygen supply-demand. | Q45810084 | ||
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude | Q48032672 | ||
Dickinson W. Richards Lecture: Circulatory adjustments to hypoxia | Q48547552 | ||
Cardiopulmonary adaptation to short-term high altitude exposure in adult Fontan patients. | Q50895129 | ||
Arrhythmic risk evaluation during exercise at high altitude in healthy subjects: role of microvolt T-wave alternans. | Q51682152 | ||
Autonomic and cardiovascular effects of acute high altitude exposure after myocardial infarction and in normal volunteers. | Q51867080 | ||
Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad | Q28217459 | ||
Effect of altitude on the heart and the lungs | Q28256321 | ||
The cerebral effects of ascent to high altitudes | Q28307435 | ||
Acute high-altitude exposure reduces lung diffusion: data from the HIGHCARE Alps project | Q30619949 | ||
Effects of hypobaric hypoxia exposure at high altitude on left ventricular twist in healthy subjects: data from HIGHCARE study on Mount Everest | Q30978544 | ||
Reduced coagulation at high altitude identified by thromboelastography | Q33453964 | ||
High-altitude hypoxia and periodic breathing during sleep: gender-related differences | Q33456807 | ||
Effects of altitude on exercise level and heart rate in patients with coronary artery disease and healthy controls | Q33764728 | ||
Effects of high altitude exposure on cerebral hemodynamics in normal subjects | Q33984847 | ||
The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness | Q34002773 | ||
Correlation between blood pressure changes and AMS, sleeping quality and exercise upon high-altitude exposure in young Chinese men. | Q35122592 | ||
Haemostasis at high altitude | Q35658147 | ||
Safety and exercise tolerance of acute high altitude exposure (3454 m) among patients with coronary artery disease | Q35771043 | ||
Adult patients with Eisenmenger syndrome report flying safely on commercial airlines | Q36172942 | ||
Chronic mountain sickness, optimal hemoglobin, and heart disease | Q36501591 | ||
Acute mountain sickness: medical problems associated with acute and subacute exposure to hypobaric hypoxia | Q36651097 | ||
Evaluating the safety of high-altitude travel in patients with adult congenital heart disease | Q37767486 | ||
Considerations on safety and treatment of patients with chronic heart failure at high altitude. | Q38116545 | ||
Cerebrovascular stroke at high altitude. | Q53644359 | ||
Short-term high altitude exposure at 3454 m is well tolerated in patients with stable heart failure | Q57095638 | ||
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: a randomized clinical trial | Q57095934 | ||
Changes in subendocardial viability ratio with acute high-altitude exposure and protective role of acetazolamide | Q57097697 | ||
Physical exertion at high altitude--another risk factor for coronary stent thrombosis? | Q57097708 | ||
Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure | Q57097762 | ||
Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects | Q57098602 | ||
Index measured at an intermediate altitude to predict impending acute mountain sickness | Q57100026 | ||
High-altitude exposure of three weeks duration increases lung diffusing capacity in humans | Q57100378 | ||
Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude | Q57100784 | ||
Frequent subclinical high-altitude pulmonary edema detected by chest sonography as ultrasound lung comets in recreational climbers | Q57101259 | ||
Impact of high altitude on echocardiographically determined cardiac morphology and function in patients with coronary artery disease and healthy controls | Q57101485 | ||
Work at high altitude after coronary stenting: safe? | Q57101805 | ||
Stroke at high altitude: Indian experience | Q57110702 | ||
Influence of acute exposure to high altitude and hypoxemia on ventricular stimulation thresholds in pacemaker patients | Q57113245 | ||
Operation Everest II: preservation of cardiac function at extreme altitude | Q57124742 | ||
Cardiac response to hypobaric hypoxia: persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest Base Camp | Q57243032 | ||
Effects of simulated altitude-induced hypoxia on exercise capacity in patients with chronic heart failure | Q73103435 | ||
Operation Everest III (Comex '97): modifications of cardiac function secondary to altitude-induced hypoxia. An echocardiographic and Doppler study | Q73321392 | ||
Periodicity of arrhythmias in healthy elderly men at the moderate altitude | Q74307582 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | high altitude | Q59775044 |
P577 | publication date | 2018-01-11 | |
P1433 | published in | European Heart Journal | Q2286839 |
P1476 | title | Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions |
Q92741635 | Effects of baseline heart rate at sea level on cardiac responses to high-altitude exposure |
Q98945637 | Evaluating Health Impact at High Altitude in Antarctica and Effectiveness of Monitoring Oxygen Saturation |
Q90647313 | Exercise responses in children and adults with a Fontan circulation at simulated altitude |
Q57091447 | Impact of residence altitude on readmission in patients with heart failure |
Q57092225 | Limitation of Maximal Heart Rate in Hypoxia: Mechanisms and Clinical Importance |
Q92825024 | Occupational and environmental influences on hypertension |
Q92586633 | PPARA genetic variants increase the risk for cardiac pumping function reductions following acute high-altitude exposure: A self-controlled study |
Q90173072 | Preserved right ventricular function but increased right atrial contractile demand in altitude-induced pulmonary hypertension |
Q57822877 | Systemic Hypertension at High Altitude |
Q99613380 | Take Me Higher: A Case of Heart Failure at High Altitude Detected Using the CardioMEMS™ HF System |
Q96641408 | The U-shaped association of altitudes with prevalence of hypertension among residents in Tibet, China |
Q64228356 | What's new in the ESC 2018 guidelines for arterial hypertension : The ten most important messages |